Amdocs (DOX) executive records small open‑market insider share sale

Rhea-AI Filing Summary

Amdocs Ltd executive Matthew E. Smith reported an open-market sale of company stock. On this Form 4, he sold 464 Ordinary Shares of Amdocs on May 29, 2026 at an average price of $62.51 per share, for roughly $29,000 in proceeds.

After the transaction, Smith directly holds 1,550 Ordinary Shares of Amdocs. The filing reflects a routine insider sale rather than a change in compensation or option exercise, and no derivative securities are reported as remaining positions.

Insider Trade Summary

Net Seller: 464 shares ($29,005)

Net Sell 1 txn

Insider Smith Matthew E.

Role See Remarks

Sold 464 shs ($29K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	464	$62.51	$29K

Holdings After Transaction: Ordinary Shares — 1,550 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 464 shares Sale price per share: $62.51 per share Approximate sale value: $29,004.64 +2 more

5 metrics

Shares sold 464 shares Ordinary Shares sold on May 29, 2026

Sale price per share $62.51 per share Average price for the 464 shares sold

Approximate sale value $29,004.64 464 shares sold at $62.51 per share

Shares held after transaction 1,550 shares Direct ownership following the May 29, 2026 sale

Net share change -464 shares Net-sell direction in transaction summary

Key Terms

Ordinary Shares, open-market sale, Form 4

3 terms

Ordinary Shares financial

"Security title is listed as Ordinary Shares for the transaction."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"The transaction action is described as an open-market sale."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The insider activity is disclosed in a Form 4 filing."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Matthew E.

(Last) (First) (Middle)

C/O AMDOCS INC

631 MARYVILLE CENTRE DRIVE, SUITE 200

(Street)

SAINT LOUIS MISSOURI 63141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMDOCS LTD [ DOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/29/2026		S		464	D	$62.51	1,550	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Secretary, Head of Investor Relations

	/s/ Smith Matthew	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Amdocs (DOX) report for Matthew E. Smith?

Amdocs executive Matthew E. Smith reported an open-market sale of 464 Ordinary Shares. The transaction occurred on May 29, 2026 and was disclosed on a Form 4 insider trading report filed with the SEC.

How many Amdocs (DOX) shares did Matthew E. Smith sell and at what price?

Matthew E. Smith sold 464 Ordinary Shares of Amdocs at an average price of $62.51 per share. This sale represents a relatively small transaction size based on the share count reported in the Form 4.

How many Amdocs (DOX) shares does Matthew E. Smith hold after this sale?

Following the reported sale, Matthew E. Smith directly holds 1,550 Ordinary Shares of Amdocs. This post-transaction holding level is disclosed in the Form 4 as the total number of shares he owns directly.

Was the Amdocs (DOX) insider transaction a buy or a sell?

The Amdocs insider transaction by Matthew E. Smith was a sale. The Form 4 lists transaction code “S” and classifies it as an open-market sale of 464 Ordinary Shares at $62.51 per share.

Did the Amdocs (DOX) Form 4 include any option exercises or derivative securities?

The Form 4 for Matthew E. Smith did not report any option exercises or derivative security transactions. The filing only shows a single non-derivative transaction involving Ordinary Shares sold in the open market.